KLF4 and atherosclerosis: Findeisen et al. [27] reported that the HDAC inhibitor trichostatin A (TSA) inhibits the proliferation of neovascular endothelial cells by inhibiting the transcriptional activity of Kruppel-like factor 4 (KLF4), suggesting that HDAC exerts a regulatory effect on atherosclerosis.